What are the different clinical features of anaphylaxis based on the trigger and which risk factors predispose to severe reactions?

Clinical Features of Anaphylaxis by Trigger and Risk Factors for Severe Reactions

Drug-induced anaphylaxis presents predominantly with cardiovascular symptoms (syncope, hypotension) and carries the highest risk for severe reactions, while food-induced anaphylaxis more commonly manifests with cutaneous symptoms (urticaria, skin findings) and gastrointestinal involvement.

Clinical Features by Trigger

Drug-Induced Anaphylaxis

• Cardiovascular predominance: Syncope and hypotension are significantly more common compared to other triggers 1
• Highest incidence of severe reactions (54.2% of cases) 1
• More likely to occur in hospitalized patients with comorbidities, infections, and polypharmacy 2
• Antibiotics are the most common drug trigger across all pediatric age groups (44.4% of drug-related cases) 3

Food-Induced Anaphylaxis

• Cutaneous and gastrointestinal predominance: Urticaria and other skin symptoms are significantly more common 1
• Vomiting occurs in 41% of cases 4
• Generally milder reactions, especially when endogenous cofactors are present 2
• Most common overall trigger (33.8-62.6% of cases) 1, 3
• Age-specific patterns:
  • Infants (<1 year): Egg allergy predominates (37.5%) 5
  • Children >6 years: Fruit allergy predominates (37.5%) 5

Venom-Induced Anaphylaxis

• May present with isolated hypotension as the only manifestation 6
• Less common in infants (low triggering role) 3
• Accounts for 10-14% of pediatric cases 1, 3

Risk Factors for Severe Reactions

Demographic Factors

• Male sex: Independent risk factor for severe anaphylaxis 1, 5
• Older age:
  • Children >6 years have higher rates of severe reactions 5
  • Older age is a general risk factor across all populations 7

Trigger-Specific Risk

• Drug-induced reactions: Highest severity risk compared to food or other allergens 1, 5
• Food-induced reactions have lower odds of severe outcomes (OR = 0.061 for drugs vs. food, p = 0.011) 4

Clinical Presentation Factors

• Rapid onset time: Shorter time to symptom development predicts severity 5
• Cardiovascular involvement: Hypotension distinguishes severe reactions (present in 45% of Grade 4 cases vs. 0% in Grade 3) 4

Comorbidities and Medications

• Lung disease (asthma) 7
• Beta-blockers 7
• ACE inhibitors 7
• Cardiovascular disease 7
• Mast cell disorders 7
• Polypharmacy and concurrent infections (particularly in drug-induced cases) 2

Hospital-Onset Anaphylaxis

• More likely to have comorbidities 2
• Associated with drug triggers rather than food 2
• Tends toward more severe presentations 2

Critical Diagnostic Considerations

Anaphylaxis diagnosis requires meeting one of three criteria 6:

1. Acute onset with skin/mucosal involvement PLUS respiratory compromise OR hypotension
2. Two or more systems involved after allergen exposure (skin, respiratory, cardiovascular, gastrointestinal)
3. Isolated hypotension after known allergen exposure

Important caveat: In children, respiratory compromise is more likely than hypotension, and shock manifests initially as tachycardia rather than hypotension 6. Pediatric hypotension definitions are age-specific: <70 mmHg (1 month-1 year), <[70 + (2×age)] mmHg (1-10 years), <90 mmHg (11-17 years) 6.

Biphasic Reactions

• Occur in 4-5% of cases (range 0.18-14.7%) using contemporary diagnostic criteria 6
• Risk factors include:
  • Delayed presentation 2
  • Elevated WBC/ANC 2
  • Older age 2
• Can occur 1-78 hours after initial reaction 6

Clinical Pitfalls

Low epinephrine administration rates persist: Only 56.9% of drug-induced and 69.7% of food-induced anaphylaxis cases receive epinephrine 1, despite it being the first-line treatment. Autoinjector prescription at discharge remains inadequate (26.7% for food-allergic patients) 4.

Male patients with drug-induced anaphylaxis require heightened vigilance given their compounded risk from both demographic and trigger-specific factors 1.